素作为潜在的抗癌剂:多机制方法的最新进展
Katya Carbone1, Fabio Gervasi1, Latipa Kozhamzharova2
1CREA-Research Centre for Olive, Fruit and Citrus Crops, Rome, Italy.
Frontiers in molecular biosciences
|June 12, 2023
概括
植物衍生性黄胺 (Casticin) 通过向多种癌症途径,显示出显著的抗癌潜力. 这种天然化合物有效诱导细胞亡,阻止细胞循环的进展,并抑制转移,为新型癌症疗法提供了一个有希望的途径.
科学领域:
- 自然产品化学 自然产品化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 植物是用于抗癌药物开发的丰富的药理活性分子来源.
- 卡斯蒂辛是一种来自*Vitex*物种的黄胺,以其抗炎和抗氧化特性而闻名.
- 新兴的研究突出显示了卡斯蒂辛对多种癌症途径的抗瘤潜力.
研究的目的:
- 为了批判性地分析casticin的抗瘤潜力.
- 为了阐明卡斯蒂辛抗瘤作用背后的分子途径.
- 审查了解卡斯蒂辛抗癌机制的最新进展.
主要方法:
- 使用"casticin"和"癌症"搜索术语对Scopus数据库进行图书统计分析.
- 使用VOSviewer软件可视化研究趋势和合作.
- 对科学文献的批判性审查,关于卡斯蒂辛的分子标和作用.
主要成果:
- 自2018年以来,已发表超过50%的虫癌症研究报告,这表明人们越来越感兴趣.
- 卡斯蒂辛作为一个拓酶IIα和DNA甲基酶1抑制剂.
- 卡斯蒂辛可上调瘤抑制的miR-338-3p,诱导细胞亡,细胞循环停止,并抑制转移.
- 卡斯蒂辛向多种与癌症相关的途径,包括表观遗传机制.
结论:
- 卡斯提辛通过调节关键分子通路,表现出广泛的抗癌活性.
- 它诱导亡,细胞循环停止和抑制转移的能力使其成为一种强大的抗癌药物.
- 卡斯蒂辛是表观遗传癌症治疗的有希望的候选者,它针对癌细胞和癌症干细胞.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K


